Behavioural effects of fluoxetine and tianeptine, two antidepressants with opposite action mechanisms, in rats

Arzneimittel-Forschung/Drug Research

Volumn 50, Issue 1, 2000, Pages 5-10

  Nowakowska, Elzbieta ^a   Kus, Krzysztof ^a   Chodera, Alfons ^a   Rybakowski, Janusz ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Antidepressants; CAS 54910 89 3; CAS 66981 73 5; Fluoxetine, behavioural effects, interaction, rat; Tianeptine, behavioural effects, interaction, rat

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; TIANEPTINE;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG MECHANISM; IMMOBILIZATION; LOCOMOTION; MALE; MEMORY; NONHUMAN; PSYCHOPHARMACOLOGY; RAT; SEDATION; SEROTONINERGIC SYSTEM; TRANQUILIZING ACTIVITY;

EID: 0033969785     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300156     Document Type: Article

References (29)

1. [1] Balleyguier, C., Sterin, D., Ziol, M. el al., Gastroenterol. Clin. Biol. 20, 607 (1996)
2. [2] Bonnyaud-Fernandez, F., Dagens, V., Ann. Psychiatr. 11, 56 (1996)
3. [3] Broqua, P., Baudrie, V., Chaouloff, F., Eur. Neuropsychopharmacol. 2, 115 (1992)
4. [4] Crawley, J. N., Pharmacol. Biochem. Behav. 15, 695 (1981)
5. [5] Curzon, G., Kennett, G. A., Sarna, G. S. et al., J. Psychiatry 160, 51 (1992)
6. [6] Dalta, K. P., Curzon, G., Neuropharmacology 32, 839 (1993)
7. [7] Delbende, C., Tranchand Bunel, D., Tarozzo, G. et al., Eur. J. Pharmacol. 251, 245 (1994)
8. [8] De-Simoni, M. G., Deluigi, A., Clavenna, A. et al., Brain Res. 574, 93 (1992)
9. [9] Dresse, A., Scuvée-Moreau, J., Mocaër, E. et al., Presse Méd. 20, 1807 (1991)
10. [10] File, S. E., Mabbutt, P. S., Drug Develop. Res. 23, 47 (1991)
11. [11] Frankfurt, M., McKittrick, C. R., McEven, B. S. et al., Brain Res. 696, 1 (1995)
12. [12] Friedman, R. A., Koesis, J. H., Psychiatr. Clin. North. Am. 19, 121 (1996)
13. [13] Frishman, W. H., Nurenberg, M., Spiegel, A., Am. J. Ther. 3, 454 (1996)
14. [14] Invernizzi, G., Pozzi, L., Garattini, S. el al., Neuropharmacol. 31, 221 (1992)
15. [15] Jaffard, R., Mocaër, E., Lebrun, C. et al., Press Méd. 20, 1812 (1991)
16. [16] Kelly, J. P., Leonhard, B. E., Rettorii, M. C, Neuropharmacology 33, 1011 (1994)
17. [17] Koshikawa, N., Mocaër, E., Stephenson, J. D., Eur. J. Pharmacol. 198, 51 (1991)
18. [18] Kuroda, Y., Watanabe, Y., McEven, B. S., Eur. J. Pharmacol. 268, R 3 (1994)
19. [19] Labrid, C., Mocaër, E., Kamoun, A., Br. J. Psych. 15, 56 (1992)
20. [20] Larrey, D., Med. Chir. Dig. 25, 139 (1996)
21. [21] Luine, V., Villegas, M., Martinez, C. et al., Brain Res. 639, 167 (1994)
22. [22] Mennini, T., Mocaër, E., Garattini, S., Naunyn-Schmiedebcrg's Arch. Pharmacol. 336, 478 (1987)
23. [23] Mocaër, E., Rettori, M. C., Kamoun, A., Clin. Neuropharmacol. 11, 32 (1988)
24. [24] Pineyro, G., Deveault, L., de Montigny, C. et al., N. S. Arch. Pharmacol. 351, 119 (1995)
25. [25] Porsolt, R. D., Anton, G., Blavet, N. et al., Eur. J. Pharmacol. 9, 201 (1979)
26. [26] Romero, G., Toscano, E., Montera, D., J. Neur. Transm. Gen. Sect. 90, 113 (1992)
27. [27] Sacchetti, G., Bonini, I., Waeterloos, G. C. et al., Eur. J. Pharmacol. 236, 171 (1993)
28. [28] Ther, L., Grundlagen der exp. Arzneimittelforschung, Wiss. Verlagsgesellschaft, Stuttgart (1965)
29. [29] Wilde, M. T., Benfiell, P., Drugs 49, 411 (1995)